M&R Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-315
Closed -$55K 501
2020
Q1
$55K Hold
315
0.02% 229
2019
Q4
$60K Sell
315
-80
-20% -$14.4K 0.01% 253
2019
Q3
$66K Sell
395
-27
-6% -$4.4K 0.02% 250
2019
Q2
$78K Sell
422
-405
-49% -$56.1K 0.02% 232
2019
Q1
$130K Sell
827
-7,040
-89% -$1.02M 0.03% 205
2018
Q4
$1.06M Sell
7,867
-1,898
-19% -$311K 0.28% 76
2018
Q3
$1.86M Sell
9,765
-78
-0.8% -$14.3K 0.41% 59
2018
Q2
$1.65M Sell
9,843
-2,948
-23% -$473K 0.38% 60
2018
Q1
$2.16M Sell
12,791
-732
-5% -$123K 0.5% 50
2017
Q4
$2.22M Sell
13,523
-3,455
-20% -$620K 0.51% 48
2017
Q3
$3.48M Buy
16,978
+55
+0.3% +$12.8K 0.84% 37
2017
Q2
$3.94M Sell
16,923
-428
-2% -$101K 0.98% 32
2017
Q1
$4.14M Buy
17,351
+649
+4% +$151K 1.04% 29
2016
Q4
$3.51M Sell
16,702
-3,183
-16% -$659K 0.95% 30
2016
Q3
$4.58M Sell
19,885
-533
-3% -$130K 1.3% 24
2016
Q2
$4.72M Sell
20,418
-3,885
-16% -$896K 1.38% 21
2016
Q1
$6.51M Buy
24,303
+936
+4% +$268K 1.96% 16
2015
Q4
$7.3M Sell
23,367
-21,829
-48% -$6.5M 2.11% 14
2015
Q3
$12.3M Sell
45,196
-699
-2% -$215K 3.39% 3
2015
Q2
$13.9M Sell
45,895
-265
-0.6% -$79K 3.29% 3
2015
Q1
$13.7M Buy
46,160
+573
+1% +$163K 3.25% 3
2014
Q4
$11.7M Sell
45,587
-1,271
-3% -$318K 2.78% 7
2014
Q3
$11.3M Sell
46,858
-1,593
-3% -$357K 2.68% 6
2014
Q2
$10.8M Buy
48,451
+3,946
+9% +$817K 2.54% 9
2014
Q1
$9.16M Buy
44,505
+42,207
+1,837% +$8.36M 2.21% 13
2013
Q4
$386 Buy
2,298
+15
+0.7% +$2.35K 0.1% 132
2013
Q3
$329K Sell
2,283
-98
-4% -$13.1K 0.09% 142
2013
Q2
$301K Buy
+2,381
New +$270K 0.09% 144

Other funds holding AGN

M&R Capital Management's AGN Position: Q2 2020 in Review

M&R Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 315 shares — an estimated $55K sold.

M&R Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $13.9M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • M&R Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • M&R Capital Management sold 315 Allergan plc shares in Q2 2020, an estimated $55K.
  • M&R Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • M&R Capital Management's Allergan plc position peaked at $13.9M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on M&R Capital Management's 13F filing for Q2 2020, filed 1 Jul 2020.